Exosome Diagnostics Garners $60,000,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3830b1ce-8276-444a-8c7e-d31d9c6ff7c7 - Date
1/7/2016 - Company Name
Exosome Diagnostics - Mailing Address
840 Memorial Drive Cambridge, MA 02139 USA - Company Description
Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids. - Website
http://www.exosomedx.com - Transaction Type
Venture Equity - Transaction Amount
$60,000,000 - Transaction Round
Series B - Proceeds Purposes
Exosome Diagnostics expects to use the funds to support the growth of its commercial diagnostics, regulatory, and companion diagnostics divisions, as well as the development of potential new diagnostic tests outside of oncology, such as in neurodegenerative diseases, and expand the development of its protein biomarker programs. These divisions and technology differentiators, such as its protein biomarker interrogation capabilities, will further distinguish Exosome Diagnostics as the industry leader in the liquid biopsy space. - M&A Terms
- Venture Investor
Forbion Capital Partners - Venture Investor
NGN Capital - Venture Investor
CD Ventures - Venture Investor
Qiagen - Venture Investor
Arcus Ventures - Venture Investor
Tiger Global Management
